Cargando…
Macrophages CD163+ and Factor XIIIa+ Provide a First-Line Defence against Proliferative Verrucous Leukoplakia Antigens
This study aimed to evaluate the density of the dendritic cells (DCs) and macrophages in oral leukoplakia (OL) and proliferative verrucous leukoplakia (PVL) by immunohistochemical analysis. We analysed paraffined tissue samples of PVL (n = 27), OL (n = 20), and inflammatory fibrous hyperplasia (n =...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10049257/ https://www.ncbi.nlm.nih.gov/pubmed/36982316 http://dx.doi.org/10.3390/ijms24065242 |
_version_ | 1785014412834242560 |
---|---|
author | Palaçon, Mariana Paravani de Oliveira Barbeiro, Camila Fernandes, Darcy Biancardi, Mariel Ruivo Silveira, Heitor Albergoni Ferrisse, Túlio Morandin León, Jorge Esquiche Kujan, Omar Bufalino, Andreia |
author_facet | Palaçon, Mariana Paravani de Oliveira Barbeiro, Camila Fernandes, Darcy Biancardi, Mariel Ruivo Silveira, Heitor Albergoni Ferrisse, Túlio Morandin León, Jorge Esquiche Kujan, Omar Bufalino, Andreia |
author_sort | Palaçon, Mariana Paravani |
collection | PubMed |
description | This study aimed to evaluate the density of the dendritic cells (DCs) and macrophages in oral leukoplakia (OL) and proliferative verrucous leukoplakia (PVL) by immunohistochemical analysis. We analysed paraffined tissue samples of PVL (n = 27), OL (n = 20), and inflammatory fibrous hyperplasia (n = 20) as the control group using the immunomarkers for DCs (CD1a, CD207, CD83, CD208 and CD123) and macrophages (CD68, CD163, FXIIIa and CD209). A quantitative analysis of positive cells in the epithelial and subepithelial areas was determined. Our results showed a reduction in CD208+ cells in the subepithelial area of the OL and PVL compared to the control. Additionally, we found a higher density of FXIIIa+ and CD163+ cells in the subepithelial area in PVL compared to the OL and control. Four-way MANOVA revealed a relationship between increased CD123+ cell density in the subepithelial area of “high-risk” samples regardless of disease. Macrophages provide the first line of defence against PVL antigens, suggesting a distinct pattern of innate immune system activation in PVL compared to OL, which may contribute to the complexity and the high rate of malignant transformation in the PVL. |
format | Online Article Text |
id | pubmed-10049257 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100492572023-03-29 Macrophages CD163+ and Factor XIIIa+ Provide a First-Line Defence against Proliferative Verrucous Leukoplakia Antigens Palaçon, Mariana Paravani de Oliveira Barbeiro, Camila Fernandes, Darcy Biancardi, Mariel Ruivo Silveira, Heitor Albergoni Ferrisse, Túlio Morandin León, Jorge Esquiche Kujan, Omar Bufalino, Andreia Int J Mol Sci Article This study aimed to evaluate the density of the dendritic cells (DCs) and macrophages in oral leukoplakia (OL) and proliferative verrucous leukoplakia (PVL) by immunohistochemical analysis. We analysed paraffined tissue samples of PVL (n = 27), OL (n = 20), and inflammatory fibrous hyperplasia (n = 20) as the control group using the immunomarkers for DCs (CD1a, CD207, CD83, CD208 and CD123) and macrophages (CD68, CD163, FXIIIa and CD209). A quantitative analysis of positive cells in the epithelial and subepithelial areas was determined. Our results showed a reduction in CD208+ cells in the subepithelial area of the OL and PVL compared to the control. Additionally, we found a higher density of FXIIIa+ and CD163+ cells in the subepithelial area in PVL compared to the OL and control. Four-way MANOVA revealed a relationship between increased CD123+ cell density in the subepithelial area of “high-risk” samples regardless of disease. Macrophages provide the first line of defence against PVL antigens, suggesting a distinct pattern of innate immune system activation in PVL compared to OL, which may contribute to the complexity and the high rate of malignant transformation in the PVL. MDPI 2023-03-09 /pmc/articles/PMC10049257/ /pubmed/36982316 http://dx.doi.org/10.3390/ijms24065242 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Palaçon, Mariana Paravani de Oliveira Barbeiro, Camila Fernandes, Darcy Biancardi, Mariel Ruivo Silveira, Heitor Albergoni Ferrisse, Túlio Morandin León, Jorge Esquiche Kujan, Omar Bufalino, Andreia Macrophages CD163+ and Factor XIIIa+ Provide a First-Line Defence against Proliferative Verrucous Leukoplakia Antigens |
title | Macrophages CD163+ and Factor XIIIa+ Provide a First-Line Defence against Proliferative Verrucous Leukoplakia Antigens |
title_full | Macrophages CD163+ and Factor XIIIa+ Provide a First-Line Defence against Proliferative Verrucous Leukoplakia Antigens |
title_fullStr | Macrophages CD163+ and Factor XIIIa+ Provide a First-Line Defence against Proliferative Verrucous Leukoplakia Antigens |
title_full_unstemmed | Macrophages CD163+ and Factor XIIIa+ Provide a First-Line Defence against Proliferative Verrucous Leukoplakia Antigens |
title_short | Macrophages CD163+ and Factor XIIIa+ Provide a First-Line Defence against Proliferative Verrucous Leukoplakia Antigens |
title_sort | macrophages cd163+ and factor xiiia+ provide a first-line defence against proliferative verrucous leukoplakia antigens |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10049257/ https://www.ncbi.nlm.nih.gov/pubmed/36982316 http://dx.doi.org/10.3390/ijms24065242 |
work_keys_str_mv | AT palaconmarianaparavani macrophagescd163andfactorxiiiaprovideafirstlinedefenceagainstproliferativeverrucousleukoplakiaantigens AT deoliveirabarbeirocamila macrophagescd163andfactorxiiiaprovideafirstlinedefenceagainstproliferativeverrucousleukoplakiaantigens AT fernandesdarcy macrophagescd163andfactorxiiiaprovideafirstlinedefenceagainstproliferativeverrucousleukoplakiaantigens AT biancardimarielruivo macrophagescd163andfactorxiiiaprovideafirstlinedefenceagainstproliferativeverrucousleukoplakiaantigens AT silveiraheitoralbergoni macrophagescd163andfactorxiiiaprovideafirstlinedefenceagainstproliferativeverrucousleukoplakiaantigens AT ferrissetuliomorandin macrophagescd163andfactorxiiiaprovideafirstlinedefenceagainstproliferativeverrucousleukoplakiaantigens AT leonjorgeesquiche macrophagescd163andfactorxiiiaprovideafirstlinedefenceagainstproliferativeverrucousleukoplakiaantigens AT kujanomar macrophagescd163andfactorxiiiaprovideafirstlinedefenceagainstproliferativeverrucousleukoplakiaantigens AT bufalinoandreia macrophagescd163andfactorxiiiaprovideafirstlinedefenceagainstproliferativeverrucousleukoplakiaantigens |